These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 9005442)

  • 1. Affinity enhancement of a recombinant antibody: formation of complexes with multiple valency by a single-chain Fv fragment-core streptavidin fusion.
    Kipriyanov SM; Little M; Kropshofer H; Breitling F; Gotter S; Dübel S
    Protein Eng; 1996 Feb; 9(2):203-11. PubMed ID: 9005442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-chain antibody streptavidin fusions: tetrameric bifunctional scFv-complexes with biotin binding activity and enhanced affinity to antigen.
    Kipriyanov SM; Breitling F; Little M; Dübel S
    Hum Antibodies Hybridomas; 1995; 6(3):93-101. PubMed ID: 8597629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linear gene fusions of antibody fragments with streptavidin can be linked to biotin labelled secondary molecules to form bispecific reagents.
    Pearce LA; Oddie GW; Coia G; Kortt AA; Hudson PJ; Lilley GG
    Biochem Mol Biol Int; 1997 Sep; 42(6):1179-88. PubMed ID: 9305536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of mono- and bivalent human single-chain Fv fragments against the D antigen in the Rh blood group: multimerization effect on cell agglutination and application to blood typing.
    Furuta M; Uchikawa M; Ueda Y; Yabe T; Taima T; Tsumoto K; Kojima S; Juji T; Kumagai I
    Protein Eng; 1998 Mar; 11(3):233-41. PubMed ID: 9613848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial expression and refolding of single-chain Fv fragments with C-terminal cysteines.
    Kipriyanov SM; Dübel S; Breitling F; Kontermann RE; Heymann S; Little M
    Cell Biophys; 1995 Jun; 26(3):187-204. PubMed ID: 8521451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bifunctional and multimeric complexes of streptavidin fused to single chain antibodies (scFv).
    Dübel S; Breitling F; Kontermann R; Schmidt T; Skerra A; Little M
    J Immunol Methods; 1995 Jan; 178(2):201-9. PubMed ID: 7836782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra- and extracellular expression of an scFv antibody fragment in E. coli: effect of bacterial strains and pathway engineering using GroES/L chaperonins.
    Dueñas M; Vázquez J; Ayala M; Söderlind E; Ohlin M; Pérez L; Borrebaeck CA; Gavilondo JV
    Biotechniques; 1994 Mar; 16(3):476-7, 480-3. PubMed ID: 7910466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved expression characteristics of single-chain Fv fragments when fused downstream of the Escherichia coli maltose-binding protein or upstream of a single immunoglobulin-constant domain.
    Hayhurst A
    Protein Expr Purif; 2000 Feb; 18(1):1-10. PubMed ID: 10648163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant single-chain Fv fragments carrying C-terminal cysteine residues: production of bivalent and biotinylated miniantibodies.
    Kipriyanov SM; Dübel S; Breitling F; Kontermann RE; Little M
    Mol Immunol; 1994 Oct; 31(14):1047-58. PubMed ID: 7935496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic engineering of streptavidin-binding peptide tagged single-chain variable fragment antibody to Venezuelan equine encephalitis virus.
    Hu WG; Alvi AZ; Fulton RE; Suresh MR; Nagata LP
    Hybrid Hybridomics; 2002 Dec; 21(6):415-20. PubMed ID: 12573105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene cloning, bacterial expression, in vitro refolding, and characterization of a single-chain Fv antibody against PreS1(21-47) fragment of HBsAg.
    Yang X; Hu W; Li F; Xia H; Zhang Z
    Protein Expr Purif; 2005 Jun; 41(2):341-8. PubMed ID: 15866720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A tetravalent single-chain antibody-streptavidin fusion protein for pretargeted lymphoma therapy.
    Schultz J; Lin Y; Sanderson J; Zuo Y; Stone D; Mallett R; Wilbert S; Axworthy D
    Cancer Res; 2000 Dec; 60(23):6663-9. PubMed ID: 11118050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an artificial antibody system with multiple valency using an Fv fragment fused to a fragment of protein A.
    Ito W; Kurosawa Y
    J Biol Chem; 1993 Sep; 268(27):20668-75. PubMed ID: 8376416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning and expression of an HIV-1 specific single-chain Fv region fused to Escherichia coli alkaline phosphatase.
    Kohl J; Rüker F; Himmler G; Razazzi E; Katinger H
    Ann N Y Acad Sci; 1991 Dec; 646():106-14. PubMed ID: 1809181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning, expression, and characterization of single-chain variable fragment antibody against mycotoxin deoxynivalenol in recombinant Escherichia coli.
    Choi GH; Lee DH; Min WK; Cho YJ; Kweon DH; Son DH; Park K; Seo JH
    Protein Expr Purif; 2004 May; 35(1):84-92. PubMed ID: 15039070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of a fusion protein of scFv-biotin mimetic peptide for immunoassay.
    Luo D; Geng M; Schultes B; Ma J; Xu DZ; Hamza N; Qi W; Noujaim AA; Madiyalakan R
    J Biotechnol; 1998 Oct; 65(2-3):225-8. PubMed ID: 9828463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High avidity scFv multimers; diabodies and triabodies.
    Hudson PJ; Kortt AA
    J Immunol Methods; 1999 Dec; 231(1-2):177-89. PubMed ID: 10648937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of a bifunctional fusion protein for ovarian cancer drug delivery: single-chain anti-CA125 core-streptavidin fusion protein.
    Wang WW; Das D; McQuarrie SA; Suresh MR
    Eur J Pharm Biopharm; 2007 Mar; 65(3):398-405. PubMed ID: 17257818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a compact anti-BAFF antibody in Escherichia coli.
    Cao P; Zhang S; Gong Z; Tang X; Cao M; Hu Y
    Appl Microbiol Biotechnol; 2006 Nov; 73(1):151-7. PubMed ID: 16625393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and biodistribution of genetically-engineered antibodies.
    Colcher D; Pavlinkova G; Beresford G; Booth BJ; Choudhury A; Batra SK
    Q J Nucl Med; 1998 Dec; 42(4):225-41. PubMed ID: 9973838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.